Is Tourette's syndrome an autoimmune disease?

Molecular Psychiatry

Volumn 7, Issue 5, 2002, Pages 437-445

  Hoekstra, Pieter J ^a   Kallenberg, C G M ^a   Korf, J ^a   Minderaa, R B ^a  

^a UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

Author keywords

Autoantibodies; Autoimmunity; Childhood; Intravenous immunoglobulins; Plasmapheresis; Streptococcus pyogenes; Tics; Tryptophan

Indexed keywords

AUTOANTIBODY; CORTICOSTEROID; IMMUNOGLOBULIN; NEURONAL AUTOANTIBODY; PENICILLIN DERIVATIVE; PLACEBO; UNCLASSIFIED DRUG; TRYPTOPHAN;

ANTIBODY DETECTION; AUTOIMMUNE DISEASE; B LYMPHOCYTE; BETA HEMOLYTIC STREPTOCOCCUS; CHILDHOOD DISEASE; CHOREA; CONCEPT FORMATION; DISEASE ASSOCIATION; DISEASE MARKER; GENE OVEREXPRESSION; GILLES DE LA TOURETTE SYNDROME; HUMAN; IMMUNOMODULATION; IMMUNOSUPPRESSIVE TREATMENT; MEDICAL RESEARCH; NEUROPSYCHIATRY; OBSESSION; PRIORITY JOURNAL; REVIEW; STREPTOCOCCUS INFECTION; SYMPTOM; TIC; VALIDATION PROCESS; BLOOD; CLASSIFICATION; IMMUNOLOGY; METABOLISM;

AUTOANTIBODIES; AUTOIMMUNE DISEASES; B-LYMPHOCYTES; HUMAN; TOURETTE SYNDROME; TRYPTOPHAN; HUMANS;

EID: 0035985459     PISSN: 13594184     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.mp.4000972     Document Type: Review

References (77)

1. The temporal dynamics of tics in Gilles de la Tourette syndrome
2. Tourette's disorder and related problems: A review and update
3. The course and prognosis of Tourette syndrome
4. Transient tic disorder and the clinical spectrum of Tourette's syndrome
5. Epidemiology of Tourette syndrome
6. Tourette syndrome. Phenomenology and classification of tics
7. Behavioral and emotional aspects of Tourette syndrome
8. Tourette's syndrome and attention-deficit hyperactivity disorder: Evidence for a genetic relationship
9. Characteristics of obsessive-compulsive symptoms in Tourette's syndrome, obsessive-compulsive disorder, and Parkinson's disease
10. Non-obscene complex socially inappropriate behavior in Tourette's syndrome
11. Pathogenesis of Tourette's syndrome
12. The genetics of Tourette syndrome
13. Genome scan for linkage to Gilles de la Tourette syndrome
14. Tourette syndrome. Treatment of tics
15. Sydenham's chorea. A model for childhood autoimmune neuropsychiatric disorders
16. Sydenham's chorea: Physical and psychological symptoms of St. Vitus dance
17. Tourette's syndrome and obsessive compulsive disorder. Clinical aspects
18. A putative poststreptococcal case of OCD with chronic tic disorder, not otherwise specified
19. Case study: Acute basal ganglia enlargement and obsessive-compulsive symptoms in an adolescent boy
20. Case study: A new infection-triggered, autoimmune subtype of pediatric OCD and Tourette's syndrome
21. Antineuronal antibodies in movement disorders
22. B lymphocyte antigen D8/17: A peripheral marker for childhood-onset obsessive-compulsive disorder and Tourette's syndrome?
23. Antibodies against human putamen in children with Tourette syndrome
24. An immunoassay for anti-neuronal antibodies associated with involuntary repetitive movement disorders
25. Antibodies against a neuron-like (HTB-10 neuroblastoma) cell in children with Tourette syndrome
26. Antibodies against neural, nuclear, cytoskeletal and streptococcal epitopes in children and Adults with Tourette's syndrome, Sydenham's chorea and Autoimmune disorders
27. Increased anti-streptococcal antibodies in patients with Tourette's syndrome
28. Group A streptococcal infections and tic disorders in an Italian pediatric population
29. Increased titers of antibodies against streptococcal M12 and M19 proteins in patients with Tourette's syndrome
30. Identification of children with pediatric autoimmune neuropsychiatric disorders associated with streptococcal infections by a marker associated with rheumatic fever
31. Elevated D8/17 expression on B-lymphocytes, a marker associated with rheumatic fever, in tic disorder patients, measured with flow cytometry
32. Increased plasma kynurenine and its relationship to neopterin and tryptophan in Tourette's syndrome
33. Increased plasma kynurenine in Tourette syndrome may be due to induction of IDO
34. Kynurenine pathway metabolities in CSF and plasma of Tourette syndrome patients
35. Cerebrospinal fluid cytokines in pediatric neuropsychiatric disease
36. Therapeutic plasma exchange and intravenous immunoglobulin for obsessive-compulsive disorder and tic disorders in childhood
37. Antibodies reacting with cytoplasm of subthalamic and caudate nuclei neurons in chorea and acute rheumatic fever
38. Antineuronal antibodies in rheumatic chorea
39. Self-reactive antibodies (natural autoantibodies) in healthy individuals
40. Guidelines on the detection of paraneoplastic anti-neuronal-specific antibodies: Report from the Workshop to the Fourth Meeting of the International Society of Neuro-Immunology on paraneoplastic neurological disease, held October 22-23, 1994, in Rotterdam, The Netherlands
41. The role of autoantibodies in autoimmune disease
42. Antistriatal antibodies in Tourette syndrome cause neuronal dysfunction
43. Cerebrospinal fluid analysis: Disease-related data patterns and evaluation programs
44. Presence of a non-HLA B cell antigen in rheumatic fever patients and their families as defined by a monoclonal antibody
45. B lymphocyte antigen D8/17 and repetitive behaviours in autism
46. Tissue distribution of antigen(s) defined by monoclonal antibody D8/17 reacting with B lymphocytes of patients with rheumatic heart disease
47. The genetics of rheumatic fever: Relationship to streptococcal infection and autoimmune disease
48. The kynurenine pathway and neurologic disease. Therapeutic strategies
49. Tryptophan metabolism in chronic inflammatory lung disease
50. Blood serotonin and tryptophan in Tourette syndrome
51. Whole blood serotonin and tryptophan levels in Tourette's disorder: Effects of acute and chronic clonidine treatment
52. Cerebrospinal fluid biogenic amines in obsessive compulsive disorder, Tourette's syndrome, and healthy controls
53. Streptococcal erythrogenic toxins induce tryptophan degradation in human peripheral blood mononuclear cells
54. Glucocorticoid induction of the rat tryptophan oxygenase gene is mediated by two widely separated glucocorticoid-responsive elements
55. Different kynurenine pathway enzymes limit quinolinic acid formation by various human cell types
56. Increased concentrations of the neurotoxin 3-hydroxykynurenine in the frontal cortex of HIV-1-positive patients
57. Relationship of neurologic status in macaques infected with the simian immunodeficiency virus to cerebrospinal fluid quinolinic acid and kynurenic acid
58. Quinolinic acid and kynurenine pathway metabolism in inflammatory and non-inflammatory neurological disease
59. Kynurenine potentiates the DOI headshake in mice
60. Superantigen-induced T cell responses in acute rheumatic fever and chronic rheumatic heart disease patients
61. Corticosteroid therapy and Tourette syndrome
62. Improvement in Gilles de la Tourette syndrome after corticosteroid therapy
63. Tourette's syndrome treated with ACTH and prednisone: Report of two cases
64. Immunoglobulin therapy in Gilles de la Tourette syndrome
65. A case of pediatric autoimmune neuropsychiatric disorders associated with streptococcal infections
66. Sydenham's chorea
67. Methods for estimating the duration of bacterial carriage
68. Infection: A stimulus for tic disorders
69. An open trial of plasma exchange in childhood-onset obsessive-compulsive disorder without poststreptococcal exacerbations
70. PANDAS: The search for environmental triggers of pediatric neuropsychiatric disorders. Lessons from rheumatic fever
71. Complex segregation analysis for obsessive compulsive disorder and related disorders
72. Postinfectious and other forms of obsessive-compulsive disorder
73. Clinical features distinguishing patients with Tourette's syndrome and obsessive-compulsive disorder from patients with obsessive-compulsive disorder without tics
74. Tourette disorder and HLA typing
75. Tourette syndrome and HLA
76. HLA typing in Tourette syndrome
77. Sydenham chorea: MR manifestations in two cases